Industry: Pharmaceuticals, Biotechnology
VLST Corporation is a privately held biotechnology company dedicated to the streamlined discovery and development of novel therapeutics for the treatment of inflammatory and autoimmune disorders. The Company’s proprietary technology platform allows for the efficient identification of high quality, validated drug targets based on a thorough understanding of virulence gene products and their function. Such an approach offers the opportunity to improve the prioritization of drug targets and reduce costs by improving the clinical success rate. The VLST discovery platform has primary applications for the treatment of rheumatoid arthritis, Crohn’s disease, multiple sclerosis, lupus and diabetes. Formed in 2004, VLST includes preeminent scientific co-founders and a seasoned leadership team. ( www.vlstcorp.com )
VLST Corp.
201 Ellliott Ave. W. Suite 450
Seattle, Washington 98119
USA
Tel: (206) 268-8550
Fax: (206) 268-8599